
Despite the significant advances in clinical research, surgical zzso zzso and chemotherapy are still used as the primary method for cancer zzso As compared to conventional therapies that often induce systemic toxicity and eventually contribute to tumor resistance, the zzso zzso zzso zzso is a promising zzso agent that selectively triggers zzso in various cancer cells by interacting with its zzso receptors zzso and zzso while sparing the normal surrounding zzso The intensive studies of TRAIL signaling pathways over the past decade have provided clues for understanding the molecular mechanisms of zzso zzso in zzso and identified an array of therapeutic responses zzso by TRAIL and its zzso zzso Analysis of its activity at the molecular level has shown that TRAIL improves survival either as zzso or zzso therapies with other zzso of zzso or zzso zzso zzso treatments amplify the activities of zzso agents and widen the therapeutic window by overcoming tumor resistance to zzso and driving cancer cells to zzso Although TRAIL sensitivity varies widely depending on the cell type, zzso cells are largely resistant to death zzso by TRAIL Death zzso zzso zzso zzso in cancer can contribute in tumor progression and often play an important role in evasion of zzso by tumor zzso zzso zzso zzso and zzso zzso have been shown to zzso tumor cells to TRAIL induced cell zzso Here, we zzso the zzso of zzso and zzso pathways and how they can be exploited toward efficient zzso therapeutic zzso 

